Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
Re: Resverlogix to press on with trial of cardiovascular drug after safety review
Regarding the timing of the FDA meetings, the slide indicated "To address any outstanding and go forward issues with the FDA we are planning for three separate meetings around years end."
